• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道阿克曼氏菌黏蛋白有利于缺血性脑卒中后的功能恢复。

Intestinal Akkermansia muciniphila is Beneficial to Functional Recovery Following Ischemic Stroke.

机构信息

Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, No. 222 South Tianshui Road, Lanzhou, Gansu Province, 730000, China.

出版信息

J Neuroimmune Pharmacol. 2024 Aug 14;19(1):43. doi: 10.1007/s11481-024-10146-6.

DOI:10.1007/s11481-024-10146-6
PMID:39141019
Abstract

Recent studies have demonstrated the interaction between gut microbiota and brain on ischemic stroke, but the roles of gut microbiota in the pathophysiology of ischemic stroke remain largely unclear. In this study, we detected a significant increase of intestinal Akkermansia muciniphila (AKK) following ischemic stroke by a rose bengal photothrombosis model. To investigate the function and mechanism of AKK on ischemic stroke, we performed the AKK administration prior to stroke surgery. The results showed that mice treated with AKK gained significantly higher body weight and behaved better than those in PBS group at 3 days after ischemic stroke. Consistently, AKK administration remarkably decreased the infarct volumes as well as the density of degenerating neurons and apoptotic cells after ischemic stroke. Notably, AKK is a potential therapeutic target in immune-related disorders connected to the microbiota, and inflammation is crucially involved in the pathophysiological process of ischemic stroke. For the determination of underlying mechanisms of this protective effect, we investigated whether there are associations between AKK and neuroinflammation following ischemic stroke. The results suggested that AKK administration significantly reduced the activation of astrocytes and microglia but up-regulated multiple anti-inflammatory factors following ischemic stroke. Therefore, our study highlighted the beneficial roles of intestinal AKK on ischemic stroke and provided a new perspective for the treatment of ischemic stroke.

摘要

最近的研究表明,肠道微生物群与脑在缺血性卒中之间存在相互作用,但肠道微生物群在缺血性卒中病理生理学中的作用在很大程度上仍不清楚。在这项研究中,我们通过玫瑰红血卟啉光血栓形成模型发现,缺血性卒中后肠道阿克曼氏菌(Akkermansia muciniphila,AKK)明显增加。为了研究 AKK 对缺血性卒中的作用和机制,我们在卒中手术前进行了 AKK 给药。结果表明,与 PBS 组相比,缺血性卒中后 3 天,接受 AKK 治疗的小鼠体重明显增加,行为表现更好。一致地,AKK 给药显著减少了缺血性卒中后的梗死体积以及变性神经元和凋亡细胞的密度。值得注意的是,AKK 是与微生物群相关的免疫相关疾病的潜在治疗靶点,炎症在缺血性卒中的病理生理过程中起着至关重要的作用。为了确定这种保护作用的潜在机制,我们研究了 AKK 与缺血性卒中后神经炎症之间是否存在关联。结果表明,AKK 给药显著减少了缺血性卒中后星形胶质细胞和小胶质细胞的激活,但上调了多种抗炎因子。因此,我们的研究强调了肠道 AKK 对缺血性卒中的有益作用,并为缺血性卒中的治疗提供了新的视角。

相似文献

1
Intestinal Akkermansia muciniphila is Beneficial to Functional Recovery Following Ischemic Stroke.肠道阿克曼氏菌黏蛋白有利于缺血性脑卒中后的功能恢复。
J Neuroimmune Pharmacol. 2024 Aug 14;19(1):43. doi: 10.1007/s11481-024-10146-6.
2
The combination of and mitigates DSS-induced colitis and attenuates colitis-associated tumorigenesis by modulating gut microbiota and reducing CD8 T cells in mice.[具体物质1]和[具体物质2]的组合通过调节肠道微生物群和减少小鼠体内的CD8 T细胞,减轻了葡聚糖硫酸钠(DSS)诱导的结肠炎,并减弱了结肠炎相关的肿瘤发生。
mSystems. 2025 Feb 18;10(2):e0156724. doi: 10.1128/msystems.01567-24. Epub 2025 Jan 22.
3
Akkermansia Muciniphila supplementation improves hyperlipidemia, cardiac function, and gut microbiota in high fat fed apolipoprotein E-deficient mice.阿克曼氏菌属黏液亚种补充改善高脂喂养载脂蛋白 E 缺陷小鼠的高脂血症、心脏功能和肠道微生物群。
Prostaglandins Other Lipid Mediat. 2024 Dec;175:106906. doi: 10.1016/j.prostaglandins.2024.106906. Epub 2024 Sep 11.
4
Beneficial effects of Akkermansia muciniphila on benign prostatic hyperplasia and metabolic syndrome.嗜黏蛋白阿克曼氏菌对良性前列腺增生和代谢综合征的有益作用。
Arch Biochem Biophys. 2025 Jun;768:110294. doi: 10.1016/j.abb.2025.110294. Epub 2025 Jan 9.
5
A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites.新一代益生菌:阿克曼氏菌黏液亚种通过调节肠道菌群和代谢物改善小鼠慢性应激诱导的抑郁样行为。
Appl Microbiol Biotechnol. 2021 Nov;105(21-22):8411-8426. doi: 10.1007/s00253-021-11622-2. Epub 2021 Oct 7.
6
Gastrointestinal Self-Adaptive and Nutrient Self-Sufficient -Gelatin Porous Microgels for Synergistic Therapy of Ulcerative Colitis.胃肠道自适应和营养自给 - 明胶多孔微凝胶用于溃疡性结肠炎的协同治疗。
ACS Nano. 2024 Oct 1;18(39):26807-26827. doi: 10.1021/acsnano.4c07658. Epub 2024 Sep 20.
7
Akkermansia muciniphila-derived extracellular vesicles mitigate smoking-induced prostate inflammation and fibrosis.嗜黏蛋白阿克曼氏菌衍生的细胞外囊泡可减轻吸烟引起的前列腺炎症和纤维化。
Int Immunopharmacol. 2025 Mar 6;149:114195. doi: 10.1016/j.intimp.2025.114195. Epub 2025 Feb 3.
8
Indole lactic acid derived from Akkermansia muciniphila activates the aryl hydrocarbon receptor to inhibit ferroptosis in ischemic stroke.源自嗜黏蛋白阿克曼氏菌的吲哚乳酸激活芳烃受体以抑制缺血性中风中的铁死亡。
Free Radic Biol Med. 2025 Jul;234:113-130. doi: 10.1016/j.freeradbiomed.2025.04.020. Epub 2025 Apr 15.
9
Influence of oral administration of Akkermansia muciniphila on the tissue distribution and gut microbiota composition of acute and chronic cadmium exposure mice.黏蛋白阿克曼氏菌口服对急性和慢性镉暴露小鼠组织分布及肠道微生物组成的影响。
FEMS Microbiol Lett. 2019 Jul 1;366(13). doi: 10.1093/femsle/fnz160.
10
Xylooligosaccharide and Akkermansia muciniphila synergistically ameliorate insulin resistance by reshaping gut microbiota, improving intestinal barrier and regulating NKG2D/NKG2DL signaling in gestational diabetes mellitus mice.低聚木糖和嗜黏蛋白阿克曼氏菌通过重塑肠道微生物群、改善肠道屏障和调节妊娠糖尿病小鼠的NKG2D/NKG2DL信号通路协同改善胰岛素抵抗。
Food Res Int. 2025 Feb;201:115634. doi: 10.1016/j.foodres.2024.115634. Epub 2024 Dec 30.

本文引用的文献

1
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.粪便微生物群移植对缺血性中风和其他神经障碍的保护作用:最新进展。
Front Immunol. 2024 Feb 21;15:1324018. doi: 10.3389/fimmu.2024.1324018. eCollection 2024.
2
Akkermansia muciniphila: A potential target and pending issues for oncotherapy.嗜黏蛋白阿克曼氏菌:肿瘤治疗的潜在靶点及待解决问题
Pharmacol Res. 2023 Oct;196:106916. doi: 10.1016/j.phrs.2023.106916. Epub 2023 Sep 9.
3
Loss of CD4 T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection.
缺失 CD4 T 细胞内源性精氨酸酶 1 可加速流感感染期间 Th1 反应动力学并减轻肺部病变。
Immunity. 2023 Sep 12;56(9):2036-2053.e12. doi: 10.1016/j.immuni.2023.07.014. Epub 2023 Aug 11.
4
Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis.膳食铁调节肠道微生物群并诱导 SLPI 分泌以促进结直肠肿瘤发生。
Gut Microbes. 2023 Jan-Dec;15(1):2221978. doi: 10.1080/19490976.2023.2221978.
5
Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration.反应性星形胶质细胞在神经炎症和神经退行性变中的功能作用。
Nat Rev Neurol. 2023 Jul;19(7):395-409. doi: 10.1038/s41582-023-00822-1. Epub 2023 Jun 12.
6
Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis.分泌型阿克曼氏菌苏氨酸 tRNA 合成酶通过监测和调节免疫稳态发挥作用。
Cell Host Microbe. 2023 Jun 14;31(6):1021-1037.e10. doi: 10.1016/j.chom.2023.05.007. Epub 2023 Jun 2.
7
Excessive consumption of mucin by over-colonized promotes intestinal barrier damage during malignant intestinal environment.过度定殖导致的黏蛋白过度消耗会在恶性肠道环境中促进肠道屏障损伤。
Front Microbiol. 2023 Mar 2;14:1111911. doi: 10.3389/fmicb.2023.1111911. eCollection 2023.
8
Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice.微生物组和空间分辨代谢组学分析揭示了肠道阿克曼氏菌通过与肿瘤内微生物群的相互作用和重塑肿瘤代谢在小鼠中的抗癌作用。
Gut Microbes. 2023 Jan-Dec;15(1):2166700. doi: 10.1080/19490976.2023.2166700.
9
High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation.高胆固醇饮食通过影响肠道微生物和神经炎症,促进小鼠出现抑郁样和焦虑样行为。
J Affect Disord. 2023 Apr 14;327:425-438. doi: 10.1016/j.jad.2023.01.122. Epub 2023 Feb 3.
10
The role of in inflammatory bowel disease: Current knowledge and perspectives.在炎症性肠病中的作用:现有知识和观点。
Front Immunol. 2023 Jan 6;13:1089600. doi: 10.3389/fimmu.2022.1089600. eCollection 2022.